BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616
67 results:

  • 1. Primary Oropharyngeal smarca4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in head and neck cancer.
    Pasricha S; Goyal S; Kamboj M; Diwan H; Gairola M; Sethi JS; Gupta M; Mehta A
    Head Neck Pathol; 2024 Mar; 18(1):16. PubMed ID: 38457069
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. brg1 mediates epigenetic regulation of TNFα-induced CCL2 expression in oral tongue squamous cell carcinoma cells.
    Xu M; Lu X; Zhu F; Sun X; Yao H; Zhang J; Chen W; Zhu H; Liu F; Shi SL; Deng X
    J Cell Biochem; 2024 Apr; 125(4):e30535. PubMed ID: 38348687
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterization of a Preclinical In Vitro Model Derived from a smarca4-Mutated Sinonasal Teratocarcinosarcoma.
    Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
    Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
    Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Divergent Lineage Markers in Anaplastic Thyroid Carcinoma.
    Mneimneh WS; Asa SL
    Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinicopathological features of olfactory carcinoma].
    Zhang CC; Li H; Cheng LQ; Wu HB
    Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1138-1143. PubMed ID: 37899320
    [No Abstract]    [Full Text] [Related]  

  • 7. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.
    Fulton-Ward T; Middleton G
    Ann Oncol; 2023 Dec; 34(12):1113-1130. PubMed ID: 37875224
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
    Laforga JB; Abdullah B
    Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Esophageal carcinoma with smarca4 mutation: Unique diagnostic challenges.
    Cui M; Lemmon K; Jin Z; Uboha NV
    Pathol Res Pract; 2023 Aug; 248():154692. PubMed ID: 37459679
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Sinonasal neoplasms: Update from the WHO 2022].
    Agaimy A
    Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Undifferentiated Carcinoma of Esophagus with smarca4 Deletion Expressing Synaptophysin: A Potential Diagnostic Pitfall.
    Cui M; Uboha N
    Int J Surg Pathol; 2024 Apr; 32(2):356-358. PubMed ID: 37143312
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma.
    Boiarsky D; Lydon CA; Chambers ES; Sholl LM; Nishino M; Skoulidis F; Heymach JV; Luo J; Awad MA; Janne PA; Van Allen EM; Barbie DA; Vokes NI
    Ann Oncol; 2023 Jul; 34(7):589-604. PubMed ID: 37121400
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
    Negrao MV; Araujo HA; Lamberti G; Cooper AJ; Akhave NS; Zhou T; Delasos L; Hicks JK; Aldea M; Minuti G; Hines J; Aredo JV; Dennis MJ; Chakrabarti T; Scott SC; Bironzo P; Scheffler M; Christopoulos P; Stenzinger A; Riess JW; Kim SY; Goldberg SB; Li M; Wang Q; Qing Y; Ni Y; Do MT; Lee R; Ricciuti B; Alessi JV; Wang J; Resuli B; Landi L; Tseng SC; Nishino M; Digumarthy SR; Rinsurongkawong W; Rinsurongkawong V; Vaporciyan AA; Blumenschein GR; Zhang J; Owen DH; Blakely CM; Mountzios G; Shu CA; Bestvina CM; Garassino MC; Marrone KA; Gray JE; Patel SP; Cummings AL; Wakelee HA; Wolf J; Scagliotti GV; Cappuzzo F; Barlesi F; Patil PD; Drusbosky L; Gibbons DL; Meric-Bernstam F; Lee JJ; Heymach JV; Hong DS; Heist RS; Awad MM; Skoulidis F
    Cancer Discov; 2023 Jul; 13(7):1556-1571. PubMed ID: 37068173
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. smarca4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.
    Neil AJ; Zhao L; Isidro RA; Srivastava A; Cleary JM; Dong F
    Mod Pathol; 2023 Jun; 36(6):100183. PubMed ID: 37054973
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MiR-199a-5p-Regulated smarca4 Promotes Oral Squamous Cell Carcinoma Tumorigenesis.
    Xu M; Zhang J; Lu X; Liu F; Shi S; Deng X
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902184
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fine needle aspiration cytology of metastatic smarca4-deficient sinonasal teratocarcinosarcoma: First report in literature.
    Gopakumar A; Kakkar A; Kaur K; Sikka K; Thakar A; Sharma A; Jain D
    Diagn Cytopathol; 2023 Apr; 51(4):E129-E136. PubMed ID: 36680532
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. SWI/SNF-deficient Sinonasal Carcinomas.
    Agaimy A
    Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A novel SMARCA2-CREM fusion expending the molecular spectrum of salivary gland hyalinazing clear cell carcinoma beyond the FET genes.
    Lanic MD; Guérin R; Sater V; Durdilly P; Ruminy P; Skálová A; Laé M
    Genes Chromosomes Cancer; 2023 Apr; 62(4):231-236. PubMed ID: 36504225
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA methylation-based classification of sinonasal tumors.
    Jurmeister P; Glöß S; Roller R; Leitheiser M; Schmid S; Mochmann LH; Payá Capilla E; Fritz R; Dittmayer C; Friedrich C; Thieme A; Keyl P; Jarosch A; Schallenberg S; Bläker H; Hoffmann I; Vollbrecht C; Lehmann A; Hummel M; Heim D; Haji M; Harter P; Englert B; Frank S; Hench J; Paulus W; Hasselblatt M; Hartmann W; Dohmen H; Keber U; Jank P; Denkert C; Stadelmann C; Bremmer F; Richter A; Wefers A; Ribbat-Idel J; Perner S; Idel C; Chiariotti L; Della Monica R; Marinelli A; Schüller U; Bockmayr M; Liu J; Lund VJ; Forster M; Lechner M; Lorenzo-Guerra SL; Hermsen M; Johann PD; Agaimy A; Seegerer P; Koch A; Heppner F; Pfister SM; Jones DTW; Sill M; von Deimling A; Snuderl M; Müller KR; Forgó E; Howitt BE; Mertins P; Klauschen F; Capper D
    Nat Commun; 2022 Nov; 13(1):7148. PubMed ID: 36443295
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeted next-generation sequencing reveals activating CTNNB1 mutations in smarca4/brg1-deficient sinonasal carcinomas: a report of two new cases and a brief review of the literature with an emphasis on histogenesis.
    Zhao M; Ma T; He X; Ge M
    Virchows Arch; 2023 Feb; 482(2):453-460. PubMed ID: 36396744
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.